Titan Pharmaceuticals Provides Additional Details on Confirmatory Phase 3 Study of Probuphine June 17, 2011
Titan Pharmaceuticals Enters Into a $20 Million Credit Facility With Deerfield Management March 16, 2011
Titan Pharmaceuticals Presents Phase 3 Probuphine™ Data at Society for Neuroscience Annual Meeting November 17, 2010
